Please join us in welcoming Alison Laws, MD, as a new faculty member in the Department of Surgery.
Alison Laws, MD
Associate Surgeon, Division of Breast Surgery
Dr. Laws graduated from the University of British Columbia and obtained her medical degree from McMaster University. She completed a general surgery residency at the University of Calgary and a breast surgical oncology fellowship at Massachusetts General Hospital/Brigham and Women’s Hospital.
She is currently pursuing a Master of Public Health in epidemiology from the Harvard T.H. Chan School of Public Health. She is a member of the Society of Surgical Oncology (SSO) and the American Society of Breast Surgeons (ASBrS).
Dr. Laws’ clinical and research interests include optimizing oncologic outcomes after breast cancer surgery, improving cancer care delivery through implementation of evidence-based practices, as well as managing patients at high-risk for breast cancer.
Chandrajit P. Raut, MD, MSc, chief of Surgical Oncology at Brigham Health and professor of surgery at Harvard Medical School, has been appointed the inaugural BWH Distinguished Chair in Surgical Oncology at Brigham and Women’s Hospital.
Chandrajit P. Raut, MD, MSc
Chief, Division of Surgical Oncology, Brigham and Women’s Hospital
Director, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Program Director, Dana-Farber/Partners CancerCare Surgical Oncology Fellowship
Professor of Surgery, Harvard Medical School
Dr. Raut, who is also the surgery director of the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute, is a graduate of Stanford University (BA/BS), University of Oxford (MSc) and Harvard Medical School (MD). He completed a residency in general surgery at Massachusetts General Hospital followed by a fellowship in surgical oncology at MD Anderson Cancer Center.
Dr. Raut is a committed clinician who specializes in the multidisciplinary care of patients with soft tissue sarcoma. He is also a prolific researcher and has a multi-PI R01 grant to evaluate an innovative drug-eluting film to be placed in the surgical bed and reduce tumor local recurrence rates. Additionally, he was co-PI on a multi-institutional phase II clinical trial evaluating five years of adjuvant imatinib for primary gastrointestinal stromal tumor (GIST), co-investigator on an international phase III randomized clinical trial evaluating the use of preoperative radiation therapy for retroperitoneal sarcomas and a member of The Cancer Genome Atlas Sarcoma (TCGA-SARC) working group of the National Institutes of Health (NIH)/National Cancer Institute (NCI).
Dr. Raut serves as section editor for sarcoma in the journals Cancer and Annals of Surgical Oncology, associate editor for the journal Sarcoma and editorial board member for the journal ACS Case Reports in Surgery. He has authored over 210 papers and over 30 book chapters and serves as the program director of the Dana-Farber/Partners CancerCare Surgical Oncology Fellowship.
Please join us in welcoming Matthew Pommerening, MD, as a new faculty member in the Department of Surgery.
Matthew Pommerening, MD
Associate Surgeon, Division of Thoracic Surgery
Dr. Pommerening is a graduate of the University of Texas at Austin. He received both his medical degree and general surgery training from the University of Texas McGovern Medical School in Houston, where he also spent time studying clinical outcomes after traumatic injury. He went on to complete a cardiothoracic surgery residency at the University of Pittsburgh Medical Center followed by a thoracic surgery fellowship at the Brigham. He is board certified in general surgery, and he is a member of the American College of Surgeons (ACS) and the Association for Academic Surgery (AAS).
In residency, Dr. Pommerening developed an interest in studying clinical outcomes and completed a two-year clinical research fellowship and a master’s degree in clinical research established by the Center for Clinical Research & Evidence-Based Medicine at McGovern Medical School.
His clinical interests include the breadth of general thoracic surgery, including minimally invasive diagnostic and interventional procedures, lung cancer and advanced foregut surgery. His research interests are focused on designing and conducting clinical trials to advance evidence-based practice in thoracic surgery.